<VariationArchive RecordType="classified" VariationID="433180" VariationName="NM_172107.4(KCNQ2):c.1610_1615del (p.Lys537_Val538del)" VariationType="Deletion" Accession="VCV000433180" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2017-08-20" MostRecentSubmission="2017-08-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="426752" VariationID="433180">
      <GeneList>
        <Gene Symbol="KCNQ2" FullName="potassium voltage-gated channel subfamily Q member 2" GeneID="3785" HGNC_ID="HGNC:6296" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63400208" stop="63472655" display_start="63400208" display_stop="63472655" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NT_187625.1" start="183" stop="33239" display_start="183" display_stop="33239" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62037541" stop="62103992" display_start="62037541" display_stop="62103992" Strand="-" />
          </Location>
          <OMIM>602235</OMIM>
          <Haploinsufficiency last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-07-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_172107.4(KCNQ2):c.1610_1615del (p.Lys537_Val538del)</Name>
      <CanonicalSPDI>NC_000020.11:63414103:TGACTTTGA:TGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63414104" stop="63414109" display_start="63414104" display_stop="63414109" variantLength="6" positionVCF="63414103" referenceAlleleVCF="CTGACTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62045457" stop="62045462" display_start="62045457" display_stop="62045462" variantLength="6" positionVCF="62045456" referenceAlleleVCF="CTGACTT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.62045460_62045465del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.62045460_62045465del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.63414107_63414112del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.63414107_63414112del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009004.2" sequenceAccession="NG_009004" sequenceVersion="2" change="g.63532_63537del">
            <Expression>NG_009004.2:g.63532_63537del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004518.6" sequenceAccession="NM_004518" sequenceVersion="6" change="c.1526_1531del">
            <Expression>NM_004518.6:c.1526_1531del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004509.2" sequenceAccession="NP_004509" sequenceVersion="2" change="p.Lys509_Val510del">
            <Expression>NP_004509.2:p.Lys509_Val510del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172106.3" sequenceAccession="NM_172106" sequenceVersion="3" change="c.1556_1561del">
            <Expression>NM_172106.3:c.1556_1561del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742104.1" sequenceAccession="NP_742104" sequenceVersion="1" change="p.Lys519_Val520del">
            <Expression>NP_742104.1:p.Lys519_Val520del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172107.4" sequenceAccession="NM_172107" sequenceVersion="4" change="c.1610_1615del" MANESelect="true">
            <Expression>NM_172107.4:c.1610_1615del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742105.1" sequenceAccession="NP_742105" sequenceVersion="1" change="p.Lys537_Val538del">
            <Expression>NP_742105.1:p.Lys537_Val538del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172108.5" sequenceAccession="NM_172108" sequenceVersion="5" change="c.1517_1522del">
            <Expression>NM_172108.5:c.1517_1522del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742106.1" sequenceAccession="NP_742106" sequenceVersion="1" change="p.Lys506_Val507del">
            <Expression>NP_742106.1:p.Lys506_Val507del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA645372661" DB="ClinGen" />
        <XRef Type="rs" ID="1555853977" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_172107.4(KCNQ2):c.1610_1615del (p.Lys537_Val538del) AND Developmental and epileptic encephalopathy, 7" Accession="RCV000497475" Version="1">
        <ClassifiedConditionList TraitSetID="6737">
          <ClassifiedCondition DB="MedGen" ID="C3150986">Developmental and epileptic encephalopathy, 7</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-05-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-05-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-08-20" MostRecentSubmission="2017-08-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6737" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15768" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy 7</ElementValue>
                <XRef ID="Epileptic+encephalopathy%2C+early+infantile%2C+7/8345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">KCNQ2-Related Neonatal Epileptic Encephalopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 7</ElementValue>
                <XRef ID="MONDO:0013387" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE7</ElementValue>
                <XRef Type="MIM" ID="613720" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13060" />
                <XRef ID="13060" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">KCNQ2-Related Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">KCNQ2-related disorders represent a continuum of overlapping neonatal epileptic phenotypes ranging from self-limited familial neonatal epilepsy (SLFNE) at the mild end to neonatal-onset developmental and epileptic encephalopathy (NEO-DEE) at the severe end. Additional, less common phenotypes consisting of neonatal encephalopathy with non-epileptic myoclonus, infantile or childhood-onset developmental and epileptic encephalopathy (DEE), and isolated intellectual disability (ID) without epilepsy have also been described. KCNQ2-SLFNE is characterized by seizures that start in otherwise healthy infants between two and eight days after term birth and spontaneously disappear between the first and the sixth to 12th month of life. There is always a seizure-free interval between birth and the onset of seizures. Seizures are characterized by sudden onset with prominent motor involvement, often accompanied by apnea and cyanosis; video EEG identifies seizures as focal onset with tonic stiffening of limb(s) and some migration during each seizure's evolution. About 30% of individuals with KCNQ2-SLFNE develop epileptic seizures later in life. KCNQ2-NEO-DEE is characterized by multiple daily seizures beginning in the first week of life that are mostly tonic, with associated focal motor and autonomic features. Seizures generally cease between ages nine months and four years. At onset, EEG shows a burst-suppression pattern or multifocal epileptiform activity; early brain MRI can show basal ganglia hyperdensities and later MRIs may show white matter or general volume loss. Moderate-to-profound developmental impairment is present.</Attribute>
                <XRef ID="NBK32534" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20437616</ID>
                <ID Source="BookShelf">NBK32534</ID>
              </Citation>
              <XRef ID="439218" DB="Orphanet" />
              <XRef ID="C3150986" DB="MedGen" />
              <XRef ID="MONDO:0013387" DB="MONDO" />
              <XRef Type="MIM" ID="613720" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1144867" SubmissionDate="2017-07-06" DateLastUpdated="2017-08-20" DateCreated="2017-08-20">
        <ClinVarSubmissionID localKey="9_July 2017|OMIM:613720" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000590882" DateUpdated="2017-08-20" DateCreated="2017-08-20" Type="SCV" Version="1" SubmitterName="Center of Genomic medicine, Geneva, University Hospital of Geneva" OrgID="505593" OrganizationCategory="laboratory" OrgAbbreviation="GenMed_GVA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.(Lys537_Val538del)</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_172107.3:c.1610_1615del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613720" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Genome_Clinic_of_Geneva-July2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1144867" TraitType="Disease" MappingType="XRef" MappingValue="613720" MappingRef="OMIM">
        <MedGen CUI="C3150986" Name="Developmental and epileptic encephalopathy, 7" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

